testing

Sam Altman didn't set out to compete with Nvidia. OpenAI began with a simple bet that better ideas, not better…
Read More...

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million USD…
Read More...